08-31-2023
EUR/share | |
Price | 82.80 |
Dividend | 1.33 |
Earnings | 4.52 |
Cash-flow | 5.52 |
Book value | 48.71 |
Equity | 45.66 |
UCB Cap is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. UCB Cap is a company from Belgium and Lux., and his stocks are publicly traded.
UCB Cap stock dividend
UCB Cap paid a total dividend of 253 million EUR last year, for a market value of 15,732 millions (Market Cap 10,019 millions). UCB Cap dividend per share is 1.33 EUR, and his stock market price 82.80 EUR.
According to the chart below, where dividend yield is displayed, UCB Cap has a dividend yield of 1.61%, lower than the amount offered by both the market average and companies from Belgium and Lux.. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare UCB Cap stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best Belgium and Lux. dividend stocks list.
UCB Cap Dividend Payout
About the ability of UCB Cap to maintain his current dividend of EUR 1.33 per share, an amount that accounts for 1.61%, we should study its payout ratio both on earnings and on cash-flows (see chart below). UCB Cap payout on ernings is currently 29.42%, which is lower than the market average, but higher than companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that UCB Cap is in a good position to keep maintaining his dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of UCB Cap is EUR 5.52 per share, which is higher than the dividend per share paid by the company of EUR 1.33, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of UCB Cap, compared againt world market average, Belgium and Lux. companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
UCB Cap Dividend History
Below you will find a table with the historical evolution of UCB Cap's dividend stock, both in percentage and in EUR, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | EUR | Paypout | Shares* |
Present | 1.61% | 1.33 | 29.42% | 190 |
2022 | 1.77% | 1.30 | 19.79% | 189 |
2021 | 1.27% | 1.27 | 25.30% | 189 |
2020 | 1.47% | 1.24 | 23.80% | 189 |
2019 | 1.71% | 1.21 | 24.59% | 189 |
2018 | 1.65% | 1.18 | 16.39% | 188 |
2017 | 1.74% | 1.15 | 31.94% | 189 |
2016 | 1.81% | 1.10 | 43.48% | 188 |
2015 | 1.25% | 1.06 | 53.54% | 190 |
*In millions
Then you can see the evolution of UCB Cap dividend stock, and compare it with the average of Belgium and Lux. stocks and that of the Pharmaceuticals and Biotechnology stocks.
UCB Cap Stock performance
Finally, last moth UCB Cap showed a return of 2.80% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 18.10% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Belgium and Lux. and Pharmaceuticals and Biotechnology firms.